Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$422M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$411M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$351M |
| 4 |
Pfizer
PFE
|
+$331M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.28B |
| 2 |
Meta Platforms (Facebook)
META
|
+$989M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$953M |
| 4 |
Amazon
AMZN
|
+$816M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$782M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.23% |
| 2 | Technology | 2.06% |
| 3 | Consumer Discretionary | 1.41% |
| 4 | Healthcare | 0.83% |
| 5 | Financials | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLFY
11226
DELISTED
Blue Foundry Bancorp
BLFY
| $106K | ﹤0.01% |
+10,966
| New | +$94.3K |
|
11227
PUT
Relmada Therapeutics
RLMD
$482M
| $106K | ﹤0.01% |
25,600
+2,300
| +10% | +$6.81K |
|
11228
CALL
BioVie
BIVI
$18.5M
| $105K | ﹤0.01% |
837
-458
| -35% | -$138K |
|
|
CIF
11229
DELISTED
MFS Intermediate High Income Fund
CIF
| $105K | ﹤0.01% |
+61,313
| New | +$98.8K |
|
|
CLSD
11230
DELISTED
Clearside Biomedical
CLSD
| $105K | ﹤0.01% |
6,006
+2,073
| +53% | +$29.6K |
|
11231
CALL
The Beachbody Company
BODI
$43.6M
| $105K | ﹤0.01% |
12,700
+12,446
| +4,900% | +$133K |
|
11232
PUT
Alpha Pro Tech
APT
$55.8M
| $105K | ﹤0.01% |
19,900
-5,500
| -22% | -$25.2K |
|
|
HSAI
11233
PUT
Hesai Group
HSAI
$2.75B
| $105K | ﹤0.01% |
+11,800
| New | +$115K |
|
11234
CALL
PMV Pharmaceuticals
PMVP
$66.3M
| $105K | ﹤0.01% |
33,900
-250,400
| -88% | -$663K |
|
11235
Quince Therapeutics
QNCX
$33.1M
| $105K | ﹤0.01% |
500
-20
| -4% | -$4K |
|
11236
PUT
American Outdoor Brands
AOUT
$131M
| $105K | ﹤0.01% |
+12,500
| New | +$107K |
|
11237
Pangaea Logistics
PANL
$517M
| $105K | ﹤0.01% |
12,735
-6,407
| -33% | -$43.1K |
|
11238
MeiraGTx Holdings
MGTX
$1.36B
| $105K | ﹤0.01% |
+14,946
| New | +$73.8K |
|
11239
Direxion Daily MSCI South Korea Bull 3X ETF
KORU
$1.6B
| $105K | ﹤0.01% |
22,324
-32,842
| -60% | -$122K |
|
|
HSAI
11240
Hesai Group
HSAI
$2.75B
| $105K | ﹤0.01% |
+11,749
| New | +$114K |
|
|
EEX
11241
PUT
DELISTED
Emerald Holding
EEX
| $105K | ﹤0.01% |
+17,500
| New | +$92K |
|
|
ALLK
11242
CALL
DELISTED
Allakos
ALLK
| $105K | ﹤0.01% |
+38,300
| New | +$86.3K |
|
11243
Franklin Wireless
FKWL
$29M
| $104K | ﹤0.01% |
30,803
+13,154
| +75% | +$39.3K |
|
11244
Westrock Coffee
WEST
$787M
| $104K | ﹤0.01% |
10,225
-64,223
| -86% | -$575K |
|
11245
Xtant Medical Holdings
XTNT
$46.3M
| $104K | ﹤0.01% |
92,305
+79,578
| +625% | +$93.6K |
|
|
CGAU
11246
CALL
Centerra Gold
CGAU
$4.74B
| $104K | ﹤0.01% |
+17,500
| New | +$95.9K |
|
11247
CALL
Gogoro
GGR
$51.6M
| $104K | ﹤0.01% |
2,020
-110
| -5% | -$5.72K |
|
11248
US Gold Corp
USAU
$273M
| $104K | ﹤0.01% |
24,408
+5,155
| +27% | +$17.7K |
|
11249
PUT
Vroom Inc
VRM
$47.7M
| $104K | ﹤0.01% |
2,158
-1,187
| -35% | -$77.5K |
|
11250
Invesco California Value Municipal Income Trust
VCV
$516M
| $103K | ﹤0.01% |
10,545
-2,824
| -21% | -$25.2K |
|
Similar funds
Jeff Yass's Q4 2023 Portfolio in Review
As of Q4 2023, Jeff Yass held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
- Jeff Yass added most to Alibaba in Q4 2023, an estimated $422M increase.
- Jeff Yass's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
- Jeff Yass fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
- Jeff Yass's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
- Jeff Yass opened 1,903 new positions and closed 1,577 in Q4 2023.
- Jeff Yass's portfolio value rose 9.3% quarter-over-quarter to $525B.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.